Mirkov Damjan, Jenetzky Ekkehart, Thieme Andrea S, Qabalan Adeeb, Gumbinger Christoph, Wick Wolfgang, Ringleb Peter A, Rizos Timolaos
Department of Neurology, University of Heidelberg, Heidelberg, Germany.
School of Medicine, Witten/Herdecke University, Witten, Germany.
Eur Stroke J. 2025 Mar;10(1):36-45. doi: 10.1177/23969873241272507. Epub 2024 Aug 26.
Patients with acute ischemic stroke (AIS) and large-vessel occlusion are frequently transferred by emergency physicians (EPs) from primary to comprehensive stroke centers (CSC) for thrombectomy, particular when thrombolysed. Data on complications during such transfers are highly limited.
Consecutive AIS patients transferred between 01/2015 and 10/2021 to our CSC were included. Associations of major (MACO) and minor (MICO) complications with clinical and imaging data were assessed.
In total, 985 patients were included in the analysis (58.5% thrombolysed). MACO developed in 1.6%, MICO in 14.6%. Compared to patients without complications (NOCO), patients with MACO did not differ in terms of demographics, cerebrovascular risk factors, or site of vessel occlusion. They had more severe strokes ( = 0.026), neurological worsening was more severe ( = 0.008), and transport duration was longer ( = 0.050) but geographical distances did not differ. Thrombolysed patients had any complication more often than patients without thrombolysis (20.3% vs 10.5%; 0.001); however, this finding was driven by patients with MICO ( 0.001) only (MACO: = 0.804). No associations were observed between stroke severity and complications in either thrombolysed or nonthrombolysed patients. Neurological deterioration during transfer was observed in 21.2%, but multivariate analysis revealed no association with thrombolysis (OR 0.962; 95%CI 0.670-1.380, = 0.832). Asymptomatic intracerebral hemorrhage was present in 1.1%, symptomatic in 0.1%.
In this large cohort, no patient-specific factor increasing the risk of complications during interhospital transfer was identified. Specifically, our results do not indicate that thrombolysis increases MACO. Hence, interhospital transfer without EPs appears reasonable in most patients.
急性缺血性卒中(AIS)合并大血管闭塞的患者常由急诊医生(EP)从基层卒中中心转至综合卒中中心(CSC)进行血栓切除术,尤其是在接受溶栓治疗后。关于此类转运过程中并发症的数据极为有限。
纳入2015年1月至2021年10月间转至我院CSC的连续性AIS患者。评估主要(MACO)和次要(MICO)并发症与临床及影像数据之间的关联。
总计985例患者纳入分析(58.5%接受了溶栓治疗)。发生MACO的患者占1.6%,发生MICO的患者占14.6%。与无并发症(NOCO)的患者相比,发生MACO的患者在人口统计学、脑血管危险因素或血管闭塞部位方面并无差异。他们的卒中病情更严重(P = 0.026),神经功能恶化更严重(P = 0.008),转运时间更长(P = 0.050),但地理距离并无差异。接受溶栓治疗的患者发生任何并发症的频率均高于未接受溶栓治疗的患者(20.3%对10.5%;P = 0.001);然而,这一发现仅由发生MICO的患者驱动(P = 0.001)(MACO:P = 0.804)。在接受溶栓治疗或未接受溶栓治疗的患者中,均未观察到卒中严重程度与并发症之间的关联。转运过程中观察到21.2%的患者出现神经功能恶化,但多因素分析显示与溶栓治疗无关(比值比0.962;95%置信区间0.670 - 1.380,P = 0.832)。无症状脑出血的发生率为1.1%,有症状脑出血的发生率为0.1%。
在这个大型队列中,未发现增加院间转运期间并发症风险的患者特异性因素。具体而言,我们的结果并未表明溶栓治疗会增加MACO。因此,在大多数患者中,无需急诊医生参与的院间转运似乎是合理的。